We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
226
Protagonist Therapeutics
PTGX
$8.55B
$10.5M 0.07%
630,000
-95,000
-13% -$1.84M
REPL icon
227
Replimune Group
REPL
$454M
$10.5M 0.07%
612,193
– –
KRTX
228
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$10.3M 0.07%
61,201
-6,000
-9% -$1.13M
HUBB icon
229
Hubbell
HUBB
$24.4B
$10.2M 0.07%
32,621
+26,240
+411% +$8.36M
EXAS
230
DELISTED
Exact Sciences
EXAS
$10M 0.07%
147,088
+137,169
+1,383% +$11.6M
ORCL icon
231
Oracle
ORCL
$339B
$9.74M 0.07%
91,987
-1,293
-1% -$150K
SPLK
232
DELISTED
Splunk Inc
SPLK
$9.6M 0.07%
65,621
-4,452
-6% -$504K
FTNT icon
233
Fortinet
FTNT
$112B
$9.49M 0.07%
161,766
-22,824
-12% -$1.51M
CLH icon
234
Clean Harbors
CLH
$17.2B
$9.39M 0.07%
56,083
-29,034
-34% -$4.89M
CM icon
235
Canadian Imperial Bank of Commerce
CM
$106B
$9.37M 0.07%
241,574
+224,810
+1,341% +$9.28M
WY icon
236
Weyerhaeuser
WY
$17.6B
$9.13M 0.06%
297,902
+241,499
+428% +$7.95M
CPNG icon
237
Coupang
CPNG
$27.2B
$8.98M 0.06%
528,000
-26,000
-5% -$467K
CLDX icon
238
Celldex Therapeutics
CLDX
$2.94B
$8.88M 0.06%
322,509
-228,000
-41% -$7.15M
CHD icon
239
Church & Dwight Co
CHD
$23.7B
$8.87M 0.06%
96,796
-65,386
-40% -$6.26M
ARVN icon
240
Arvinas
ARVN
$530M
$8.79M 0.06%
447,551
-20,002
-4% -$491K
VTR icon
241
Ventas
VTR
$47.5B
$8.79M 0.06%
208,616
+167,472
+407% +$7.54M
MRSH
242
Marsh
MRSH
$94.3B
$8.72M 0.06%
45,847
+8,827
+24% +$1.69M
BRKR icon
243
Bruker
BRKR
$9.4B
$8.67M 0.06%
139,186
+30,000
+27% +$2.02M
KMB icon
244
Kimberly-Clark
KMB
$37.6B
$8.51M 0.06%
70,409
+43,761
+164% +$5.65M
TEX icon
245
Terex
TEX
$7.37B
$8.5M 0.06%
147,549
+69,291
+89% +$4.13M
IEX icon
246
IDEX
IEX
$17B
$8.47M 0.06%
40,697
+14,124
+53% +$3.06M
WDAY icon
247
Workday
WDAY
$41.5B
$8.35M 0.06%
38,877
+21,771
+127% +$5.05M
DELL icon
248
Dell
DELL
$239B
$8.26M 0.06%
119,812
-29,768
-20% -$1.77M
EW icon
249
Edwards Lifesciences
EW
$49.4B
$8.23M 0.06%
118,745
-76,295
-39% -$6.13M
INSM icon
250
Insmed
INSM
$22.4B
$8.21M 0.06%
325,200
-482,000
-60% -$11M
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.